Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial.

@article{Lodge2005RecombinantCF,
  title={Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial.},
  author={J. Peter A. Lodge and Sven Jonas and Elie Oussoultzoglou and Massimo Mal{\'a}go and Christian Jayr and Daniel Cherqui and Matthias Anthuber and Darius Feroze Mirza and Luce Kuhlman and W O Bechstein and Juan Carlos Diaz and Jack Tartiere and Daniel Eyraud and Marianne J Fridberg and Elisabeth Erhardtsen and Oliver Mimoz},
  journal={Anesthesiology},
  year={2005},
  volume={102 2},
  pages={269-75}
}
BACKGROUND Prevention of bleeding episodes in noncirrhotic patients undergoing partial hepatectomy remains unsatisfactory in spite of improved surgical techniques. The authors conducted a randomized, placebo-controlled, double-blind trial to evaluate the hemostatic effect and safety of recombinant factor VIIa (rFVIIa) in major partial hepatectomy. METHODS Two hundred four noncirrhotic patients were equally randomized to receive either 20 or 80 microg/kg rFVIIa or placebo. Partial hepatectomy… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 60 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

medicine

  • PW Friederich, CP Henny, +5 authors M Levi
  • 2002

Similar Papers

Loading similar papers…